Your basket is currently empty!
» Kidney Cancer News » Welsh Government to give cancer patients in Wales access to new drugs
Welsh Government to give cancer patients in Wales access to new drugs
A deal has been announced by the Welsh Government to give cancer patients in Wales access to new drugs which aren’t routinely available.
The agreement with pharmaceutical company Novartis is the first of its kind in Wales, and will allow patients access to the medicine ‘ everolimus’.
Marketed under the trade names ‘Afinitor’ and ‘Votubia’, it can treat certain types of advanced renal, pancreatic and breast cancers.
It can also be used to treat non-cancerous brain and kidney tumours.
To read the full story CLICK HERE
Malcolm Packer
Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.